TAVR - PROTECTED TAVR

Stroke Prevention with Sentinel During Transcatheter Aortic Valve Replacement under the direction of Dr. Raymond McKay and the Structural Heart team.

This study hopes to demonstrate that use of the Sentinel Cerebral Protection System significantly reduces the risk of peri-procedural stroke <72 hours after transcatheter aortic valve replacement (TAVR).

Eligibility:

• Patients undergoing commercial transcatheter aortic valve replacement with femoral access.

THIS STUDY IS CLOSED TO ENROLLMENT

Please contact Jill Cloutier, Coordinator at 860-972-2579 or email at [email protected] for additional information.